Christopher Hite - 08 May 2025 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
EVP & Vice Chairman
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Christopher Hite
Issuer symbol
RPRX
Transactions as of
08 May 2025
Net transactions value
$0
Form type
4
Filing time
09 May 2025, 17:14:15 UTC
Previous filing
18 Feb 2025
Next filing
20 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hite Christopher EVP & Vice Chairman C/O ROYALTY PHARMA PLC, 110 E. 59TH STREET, NEW YORK /s/ Sean Weisberg, as Attorney-in-Fact for Christopher Hite 09 May 2025 0001814238

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $0 +48,646 +8.1% $0.000000 648,646 08 May 2025 By SCH Investment Partners LLC F1
holding RPRX Class A Ordinary Shares 70,000 08 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney